Dr. Lily Adams is a scientist with hands-on laboratory experience in infectious diseases and biotechnological applications. She holds a Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill, as well as a M.S. in Bioinformatics and B.S. in Biotechnology and Molecular Bioscience from the Rochester Institute of Technology. Dr. Adams’ experience spans from computational biology to molecular virology, including BSL3 and Select Agent research. At Gryphon, she uses her practical skills and knowledge to increase global preparedness for biological pathogens and new developments in biotechnology.